Dr. Mir-Farzin Mashreghi

Since 2023
Deputy Scientific Director at DRFZ (since May 2023)

Since 2022
Head of the third Research Area “Systems Rheumatology” at the DRFZ (November 2022)

2020-2022
Group Leader of the joint DRFZ/BIH Center for Regenerative Therapies (B-CRT) “Single-Cell-Laboratory for Advanced Cellular Therapies”.

Since 2018
Scientific Head “Next Generation Sequencing”, Leader of the Laboratory of Molecular Rheumatology “Regine von Ramin Labor” at the DRFZ.

Since 2016
Group Leader “Therapeutic Gene Regulation”, Programme Area III: Regenerative Rheumatology at the DRFZ Berlin.

2007 –2016
Research Associate at the Cell Biology department (Head: Prof. Dr. Andreas Radbruch) at the DRFZ Berlin.

2024
Fachimmunologe der Deutschen Gesellschaft für Immunologie (DGFI)

2003 –2007
PhD thesis at the Charité Universitätsmedizin Berlin, Institute of Medical Immunology, Supervisors: Prof. Dr. H.-D. Volk / Prof. Dr. P.-M. Kloetzel; “Functional analysis of the transcription factor STAT3 regulated by the induction of the cytoprotective enzyme heme oxygenase-1”, magna cum laude

2002 –2003
Diploma thesis at the Charité Universitätsmedizin Berlin, Institute of Medical Immunology, Supervisor, Prof. Dr. H.-D. Volk; “Strategies for the diagnosis of subclinical and clinical acute rejection episodes in renal transplantation”

1998 –2003
University studies at the Freie Universität Berlin, Department of Biology, Pharmacy und Chemistry, Field: Biochemistry diploma, Subjects: Biochemistry, Biophysics, Immunology, Biology, Organic Chemistry, Physical Chemistry and Physics. Mark: Excellent

Since 2023
DRFZ Lead PI, Area “Immunity, Inflammation and Infection” of the „Deutsches Zentrum für Kinder und Jugendgesundheit“, Berlin Location

2018-2023
Study Group Coordinator of EFIS-IL-Study Group “Non-coding RNA and epigenetic regulation in immune cells”

Deutsche Gesellschaft für Immunologie (DGFI)

Wolfgang Schulze Award 2011, „Therapeutic use of microRNAs in rheumatology“